Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own
View analytic
Sunday, March 26 • 12:30pm - 1:15pm
Therapeutic Drug Monitoring in IMIDs: Biologic Agents

Sign up or log in to save this to your schedule and see who's attending!

Numerous factors have been identified that impact upon pharmacokinetic/pharmacodynamic effects of drugs used to treat IMIDs, including immunosuppressive and biologic therapies.
Therapeutic drug monitoring has been utilized to rationalize approaches to loss of response and are increasing used, proactively, to maintain response to conventional and biologic therapy. Examples of the role of TDM will be discussed as a means to both treat to target and personalize therapies in IMIDs.

Speakers
avatar for Stephen B. Hanauer, MD

Stephen B. Hanauer, MD

Clifford Joseph Barborka Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Digestive Health Center
Stephen B. Hanauer is past President of the American College of Gastroenterology.  He completed a medical degree, with honors, at the University of Illinois in Chicago. His postdoctoral training included an internship and residency in internal medicine, as well as a fellowship in gastroenterology, at the University of Chicago.  He rose through academic ranks to become Professor of Medicine and subsequently was awarded the Joseph B... Read More →


Sunday March 26, 2017 12:30pm - 1:15pm
TBA